Part 13/13:
Countries like Israel showcase that widespread vaccination combined with digital health passes can restart social and cultural activities, serving as potential models. Conversely, hesitant nations with low vaccination rates or internal disputes over privacy rights face an uncertain path to reopening.
India’s expansive vaccine manufacturing capacity demonstrates that robust production capabilities are essential to meet global demand and support reopening strategies worldwide. However, balancing domestic needs with international commitments remains a delicate endeavor.
As the world strives for a resilient and inclusive recovery, collaboration, technological innovation, and equitable vaccine access will be critical to turning the hope of renewed travel and economic stability into reality.